Showing results (1-10 of 123) with videos related to
Sort By:
Pageof 13
Epileptic Disorders : International Epilepsy Journal with Videotape|June 3, 2005
Temporal lobe epilepsy: clinical semiology and age at onsetVicente Villanueva, José Maria SerratosaRevista De Neurologia|April 10, 2013
[Zonisamide in the epilepsy treatment: a literature review from add-on therapy to monotherapy]Vicente Villanueva, Pedro J Serrano-CastroThe Neurologist|February 20, 2009
Management of epilepsy in oncological patientsVicente Villanueva, Montserrat Codina, Eloy ElicesScientific Reports|February 28, 2023
Patient profile, management, and quality of life associated with Dravet syndrome: a cross-sectional, multicentre study of 80 patients in SpainAntonio Gil-Nagel, Rocío Sánchez-Carpintero, Vicente VillanuevaJournal of Neurology|September 24, 2022
Antiseizure medications (antiepileptic drugs) in adults: starting, monitoring and stoppingHeather Angus-Leppan, Michael R Sperling, Vicente VillanuevaIEEE Transactions on Neural Networks and Learning Systems|March 3, 2017
Probabilistic Distance for Mixtures of Independent Component AnalyzersGonzalo Safont, Addisson Salazar, Luis Vergara, et al.Seizure|January 26, 2020
Safety, tolerability and effectiveness of transition to eslicarbazepine acetate from carbamazepine or oxcarbazepine in clinical practiceRodrigo Rocamora, Jukka Peltola, Giovanni Assenza, et al.Neurology and Therapy|September 26, 2018
Dibenzazepine Agents in Epilepsy: How Does Eslicarbazepine Acetate Differ?Charlotte Lawthom, Jukka Peltola, Rob McMurray, et al.Neurology and Therapy|May 18, 2019
Effectiveness and Safety/Tolerability of Eslicarbazepine Acetate in Epilepsy Patients Aged ≥ 60 Versus < 60 Years: A Subanalysis from the Euro-Esli StudyCharlotte Lawthom, Pedro Bermejo, Dulce Campos, et al.Journal of Neurology|August 25, 2023
Clinical and economic implications of epilepsy management across treatment lines in Spain: a real-life database analysisRafael Toledano, Vicente Villanueva, Manuel Toledo, et al.Pageof 13